Login
Toggle navigation
Login
Cart
Contact Us
Search
Search
Exploring the Evidence: Is Intravenous Ascorbic Acid An Effective and Safe Option For Increasing Hemoglobin Levels In Patients with a Hyporesponse To Epoetin Alfa?
Identification:
nnj_maD4
Issue:
March-April 2012
Volume:
Vol. 39, No. 2
Standard: $30.00
Add to Cart
Overview
Comments
Author(s)
Tamara M. Kear, PhD, RN, CNN, FAAN
, Executive Director, American Nephrology Nurses Association (ANNA)
Credits
Credits: None available.
You must be logged in and own this product in order to post comments.
×
References
×
Shopping Cart
Item
Price
Remove